by Desiree Cobb-Olori | Sep 26, 2015
doi: 10.1371/journal.pone.0134572. eCollection 2015. Brunner D., Kabitzke P., He D., Cox K., Thiede L., Hanania T., He D., Sabath E., Alexandrov V., Saxe M., Peles E., Mills A., Spooren W., Ghosh A., Feliciano P., Benedetti M., Clayton AL., Biemans B. PLoS One 2015...
by Desiree Cobb-Olori | Mar 5, 2015
Alexandrov V, Brunner D, Hanania T, Leahy E European Journal of Pharmacology.750 2015 82-89 DOI: 10.1016/j.ejphar.2014.11.047 Drug testing with traditional behavioral assays constitutes a major bottleneck in the development of novel therapies. PsychoGenics developed...
by Desiree Cobb-Olori | Sep 1, 2014
To study the effect of a novel matrix metalloproteinease-2 (MMP-2) and MMP–9 inhibitor, AQU-118, on mechanical allodynia in the spinal nerve ligation (SNL) model of neuropathic pain, and the chronic constriction injury of the infraorbital nerve (CCI-IoN) model of...
by Desiree Cobb-Olori | Aug 26, 2014
Menalled L & Brunner D. 29(11): 1375-90 2014
by Desiree Cobb-Olori | Jun 25, 2014
Menalled LB, Kudwa A, Oakeshott S, Farrar A, Paterson N, Filippov I, Miller S, Kwan M, Olsen M, Beltran J, Torello J, Fitzpatrick J, Mushlin R, Cox K, McConnell K, Mazzella M, He D, Osborne GF, Al-Nackkash R, Bates GP, Tuunanen P, Lehtimaki K, Brunner D, Ghavami A,...
